NEW YORK (GenomeWeb) – Applied BioCode today said it has expanded an existing licensing and supply agreement with PerkinElmer for the use of Applied BioCode's Barcoded Magnetic Bead technology. 

The amended non-exclusive deal provides PerkinElmer access to Applied BioCode's 4,096-plex BMB patents, as well as the BioCode MDx 3000 high-throughput system for the Asian markets. PerkinElmer will develop market-specific multiplexed molecular diagnostics for infectious diseases for the BioCode MDx 3000 platform and distribute them into select Asian markets, Applied BioCode said. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.